Patients treated with VD-PACE had a lower ORR (57%) compared to those receiving other regimens (94%), but this difference did not reach statistical significance ( P =0.053; Online Supplementary Figure S2B ).
← all excerpts
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era.
1
0.0530
0.0530